Cart
sales@molnova.com
ML167
CAS No. 1285702-20-6
ML167 ( ML-167;ML 167 )
Catalog No. M11167 CAS No. 1285702-20-6
A potent, selective CDC-like kinase 4 (CLK4) inhibitor with IC50 of 136 nM, >10-fold selectivity over Clk1, Clk2, Clk3, Dyrk1A/1B.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 41 | Get Quote |
|
| 5MG | 63 | Get Quote |
|
| 10MG | 105 | Get Quote |
|
| 25MG | 217 | Get Quote |
|
| 50MG | 371 | Get Quote |
|
| 100MG | 552 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameML167
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective CDC-like kinase 4 (CLK4) inhibitor with IC50 of 136 nM, >10-fold selectivity over Clk1, Clk2, Clk3, Dyrk1A/1B.
-
DescriptionA potent, selective CDC-like kinase 4 (CLK4) inhibitor with IC50 of 136 nM, >10-fold selectivity over Clk1, Clk2, Clk3, Dyrk1A/1B.
-
SynonymsML-167;ML 167
-
PathwayCell Cycle/DNA Damage
-
TargetCLK
-
RecptorCLK1;CLK2;CLK4;Dyrk1B
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number1285702-20-6
-
Formula Weight335.36
-
Molecular FormulaC19H17N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 62 mg/mL (184.9 mM); Ethanol: 11 mg/mL (32.8 mM); Water: <1 mg/mL （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESOCC1=CC=C(C2=CC3=C(NCC4=CC=C(C)O4)N=CN=C3C=C2)O1
-
Chemical Name5-[4-[[(5-Methyl-2-furanyl)methyl]amino]-6-quinazolinyl]-2-furanmethanol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
K00546
K00546 is a potent inhibitor of the CDC2-like kinase CLK1 and CLK3 with IC50 of 8.9 and 29.2 nM, respectively.
-
TG693
TG693 is an orally available, selective, ATP-competitive CLK1 inhibitor with IC50 of 112.6 nM.
-
MU1210
MU1210 (MU-1210) is a potent and highly selective inhibitor of cdc-like kinases (CLKs) with IC50 of 51 nM.
